Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
97.115,90
-0,09%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Relmada Therapeutics Inc (RLMD) Relmada Therapeutics Inc (RLMD) Notizie

Relmada Therapeutics Inc

RLMD
0,3722
0,0195 (5,53%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202413:49EDGAR2Form 8-K - Current report
04/12/202413:30EDGAR2Form 8-K - Current report
14/11/202415:41EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/9/202403:36PRNUSKuehn Law Encourages Investors of Relmada Therapeutics, Inc...
13/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
11/9/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202422:23EDGAR2Form S-3 - Registration statement under Securities Act of..
07/8/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202420:47PRNUSKuehn Law Encourages Investors of Relmada Therapeutics, Inc...
30/5/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/3/202412:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
20/2/202423:55EDGAR2Form 144 - Report of proposed sale of securities
01/2/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:30EDGAR2Form 8-K - Current report
04/1/202414:11EDGAR2Form 8-K - Current report
03/1/202423:00EDGAR2Form 8-K - Current report
Apertura: 0,343 Min: 0,343 Max: 0,38
Chiusura: 0,3527

La tua Cronologia

NASDAQ
RLMD
Relmada Therapeutics
LSE
0LRV
Budimex
TG
A2R2L4
Liberty Mutual
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network